{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"cerebrolysin","title":"cerebrolysin","body":"## Overview\nEvidence is being populated by Grok web search.","hero":null,"images":[],"style":{},"tags":[],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/cerebrolysin/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/39832667/","title":"The possible role of cerebrolysin in the management of vascular dementia: Leveraging concepts","quote":"CBL could be effective therapeutic strategy in preventing and treating VD by targeting neuroinflammation, BBB injury, and chronic cerebral hypoperfusion.","summary":"2025 review discussing Cerebrolysin (CBL) as a potential treatment for vascular dementia via anti-inflammatory and neuroprotective mechanisms.","author":"","publisher":"","date":"","claim_ids":[],"found_by":"grok-4.3","extra":{},"accessed_at":"2026-06-29T16:54:15.129Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"1286105d9a205b7bcfc12cc03292be2a61fe2fc4d85bcb1e972d89cdd39a4399"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/39957612/","title":"Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study","quote":"Cerebrolysin combined with speech and language therapy offers promising potential for enhancing recovery in poststroke nonfluent aphasia.","summary":"2025 randomized pilot study (ESCAS) showing benefits of Cerebrolysin plus speech therapy for post-stroke aphasia recovery.","author":"","publisher":"","date":"","claim_ids":[],"found_by":"grok-4.3","extra":{},"accessed_at":"2026-06-29T16:54:15.129Z","link_status":"ok","quote_status":"verified","prev":"1286105d9a205b7bcfc12cc03292be2a61fe2fc4d85bcb1e972d89cdd39a4399","hash":"b035aaffced9e5c80d38e031e91553022418dc7d2fe11d3967fcc875358b1c18"},{"id":"s3","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT06897176","title":"Effects of Cerebrolysin on Language Ability in Non-fluent Aphasia After Stroke","quote":"This study aims to measure changes in language ability after adding cerebrolysin to standard treatment for non-fluent aphasia patients with post-stroke ...","summary":"Ongoing 2025 clinical trial evaluating Cerebrolysin for language recovery in post-stroke non-fluent aphasia.","author":"","publisher":"","date":"","claim_ids":[],"found_by":"grok-4.3","extra":{},"accessed_at":"2026-06-29T16:54:15.129Z","link_status":"ok","quote_status":"unverified","prev":"b035aaffced9e5c80d38e031e91553022418dc7d2fe11d3967fcc875358b1c18","hash":"ddcc96d4165b780c8a4220b08b6b5a8c02a1ce3bc0617f4e216ae07cc8e400d5"},{"id":"s4","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT06677502","title":"Cerebrolysin in Critically Ill Patients With Delirium","quote":"Cerebrolysin, 50 mL daily administered intravenously for seven consecutive days, reduces or alleviates the severity of delirium detected by the CAM-ICU test.","summary":"2025 clinical trial testing Cerebrolysin for reducing delirium severity in critically ill patients.","author":"","publisher":"","date":"","claim_ids":[],"found_by":"grok-4.3","extra":{},"accessed_at":"2026-06-29T16:54:15.129Z","link_status":"ok","quote_status":"unverified","prev":"ddcc96d4165b780c8a4220b08b6b5a8c02a1ce3bc0617f4e216ae07cc8e400d5","hash":"0ac9b7421280e331ebd53e60b0f2759d33fc5c14a43d379c7271b8093b3d5f22"},{"id":"s5","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41018475/","title":"Safety and Efficacy of Cerebrolysin for Neurorecovery After Acute Ischemic Stroke","quote":"These findings suggest that Cerebrolysin significantly enhances early neurological recovery after ischemic stroke, with a comparable safety profile.","summary":"2025 study/meta-analysis supporting Cerebrolysin for improved neurorecovery post-ischemic stroke.","author":"","publisher":"","date":"","claim_ids":[],"found_by":"grok-4.3","extra":{},"accessed_at":"2026-06-29T16:54:15.129Z","link_status":"ok","quote_status":"verified","prev":"0ac9b7421280e331ebd53e60b0f2759d33fc5c14a43d379c7271b8093b3d5f22","hash":"e54f5ee0280583394277c94491345066bbc3ea46808106ab606a2e4f24bdde0b"},{"id":"s6","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/40851188/","title":"C-REGS2-A multinational, high-quality comparative ...","quote":"The results of the C-REGS2 study showed the effectiveness and safety of Cerebrolysin treatment for moderate acute IS in real-world clinical practice.","summary":"2025 real-world study (C-REGS2) confirming efficacy and safety of Cerebrolysin in acute ischemic stroke.","author":"","publisher":"","date":"","claim_ids":[],"found_by":"grok-4.3","extra":{},"accessed_at":"2026-06-29T16:54:15.129Z","link_status":"ok","quote_status":"verified","prev":"e54f5ee0280583394277c94491345066bbc3ea46808106ab606a2e4f24bdde0b","hash":"71417b896315d9b314b4f68b02784ad9618d456cdfc55b17efb0f6977966d2e5"},{"id":"s7","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/40325343/","title":"Efficacy of Cerebrolysin Treatment as an Add-On Therapy to Mechanical Thrombectomy in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion in Anterior Circulation: Results of a 3-Month Follow-up of a Prospective, Open Label, Single-Center Study","quote":"Cerebrolysin improved functional outcomes at 90 days, accelerated neurological recovery, and reduced complications post-MT in patients with small ischemic core,","summary":"2025 study showing benefits of Cerebrolysin as add-on to mechanical thrombectomy in acute ischemic stroke.","author":"","publisher":"","date":"","claim_ids":[],"found_by":"grok-4.3","extra":{},"accessed_at":"2026-06-29T16:54:37.763Z","link_status":"ok","quote_status":"verified","prev":"71417b896315d9b314b4f68b02784ad9618d456cdfc55b17efb0f6977966d2e5","hash":"b7799f17e305d4ab9e3a15b82738f8dc174e29b9f9cdf4c953dc0e5b1a6b916c"},{"id":"s8","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41010922/","title":"Evaluating the Effect of Cerebrolysin as an Adjuvant to Standard Therapy in Patients with Acute Ischemic Stroke: A Prospective Observational Study","quote":"Cerebrolysin, a neuropeptide with neuroprotective and neurotrophic properties, may enhance post-stroke recovery . This study evaluated the impact","summary":"2025 prospective observational study on Cerebrolysin adjuvant in acute ischemic stroke.","author":"","publisher":"","date":"","claim_ids":[],"found_by":"grok-4.3","extra":{},"accessed_at":"2026-06-29T16:54:37.763Z","link_status":"ok","quote_status":"unverified","prev":"b7799f17e305d4ab9e3a15b82738f8dc174e29b9f9cdf4c953dc0e5b1a6b916c","hash":"4c40d8d18f06c59ba3cbf412398101cb9c308b3492ffdeae2d2445e9ba307b3e"},{"id":"s9","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41349847/","title":"Cerebroprotection in acute ischemic stroke: Perspectives on combining Cerebrolysin with recanalization therapy","quote":"This article provides perspectives on the use of Cerebrolysin as an adjunct treatment to reperfusion therapy in acute ischemic stroke (AIS).","summary":"2025/2026 perspectives/review on Cerebrolysin with recanalization in AIS.","author":"","publisher":"","date":"","claim_ids":[],"found_by":"grok-4.3","extra":{},"accessed_at":"2026-06-29T16:54:37.763Z","link_status":"ok","quote_status":"verified","prev":"4c40d8d18f06c59ba3cbf412398101cb9c308b3492ffdeae2d2445e9ba307b3e","hash":"b24406f09d2a34983eca65d5f3b458bd037f35c454c8570a508a9984120267d0"}],"reviews":[],"extra":{},"has_traversal":false,"register":"standard","status":"published","revisions":2,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T16:53:56.542Z","model":"grok-4.3","role":"writer","action":"draft","payload":{"title":"cerebrolysin","register":"standard","body":"## Overview\nEvidence is being populated by Grok web search.","claims":[],"sources":[]},"rationale":"","tokens_in":0,"tokens_out":0,"cost":0,"prev_hash":"genesis","hash":"e5cdf02f89b701a81266a29e1414292dfff9d2dcc2c2e23a3d7aea480c4d0a4a"},{"seq":1,"id":"k2","ts":"2026-06-29T16:54:15.944Z","model":"grok-4.3","role":"source_hunt","action":"sources","payload":{"added":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/39832667/","title":"The possible role of cerebrolysin in the management of vascular dementia: Leveraging concepts","quote":"CBL could be effective therapeutic strategy in preventing and treating VD by targeting neuroinflammation, BBB injury, and chronic cerebral hypoperfusion.","link_status":"ok","quote_status":"verified"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/39957612/","title":"Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study","quote":"Cerebrolysin combined with speech and language therapy offers promising potential for enhancing recovery in poststroke nonfluent aphasia.","link_status":"ok","quote_status":"verified"},{"id":"s3","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT06897176","title":"Effects of Cerebrolysin on Language Ability in Non-fluent Aphasia After Stroke","quote":"This study aims to measure changes in language ability after adding cerebrolysin to standard treatment for non-fluent aphasia patients with post-stroke ...","link_status":"ok","quote_status":"unverified"},{"id":"s4","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT06677502","title":"Cerebrolysin in Critically Ill Patients With Delirium","quote":"Cerebrolysin, 50 mL daily administered intravenously for seven consecutive days, reduces or alleviates the severity of delirium detected by the CAM-ICU test.","link_status":"ok","quote_status":"unverified"},{"id":"s5","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41018475/","title":"Safety and Efficacy of Cerebrolysin for Neurorecovery After Acute Ischemic Stroke","quote":"These findings suggest that Cerebrolysin significantly enhances early neurological recovery after ischemic stroke, with a comparable safety profile.","link_status":"ok","quote_status":"verified"},{"id":"s6","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/40851188/","title":"C-REGS2-A multinational, high-quality comparative ...","quote":"The results of the C-REGS2 study showed the effectiveness and safety of Cerebrolysin treatment for moderate acute IS in real-world clinical practice.","link_status":"ok","quote_status":"verified"}]},"rationale":"auto-populate round 1","tokens_in":0,"tokens_out":0,"cost":0,"prev_hash":"e5cdf02f89b701a81266a29e1414292dfff9d2dcc2c2e23a3d7aea480c4d0a4a","hash":"3124f8727002d44ac332811f19ef6ce5a6044c2ee998b2193cde18c4ee965c57"},{"seq":2,"id":"k3","ts":"2026-06-29T16:54:38.394Z","model":"grok-4.3","role":"source_hunt","action":"sources","payload":{"added":[{"id":"s7","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/40325343/","title":"Efficacy of Cerebrolysin Treatment as an Add-On Therapy to Mechanical Thrombectomy in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion in Anterior Circulation: Results of a 3-Month Follow-up of a Prospective, Open Label, Single-Center Study","quote":"Cerebrolysin improved functional outcomes at 90 days, accelerated neurological recovery, and reduced complications post-MT in patients with small ischemic core,","link_status":"ok","quote_status":"verified"},{"id":"s8","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41010922/","title":"Evaluating the Effect of Cerebrolysin as an Adjuvant to Standard Therapy in Patients with Acute Ischemic Stroke: A Prospective Observational Study","quote":"Cerebrolysin, a neuropeptide with neuroprotective and neurotrophic properties, may enhance post-stroke recovery . This study evaluated the impact","link_status":"ok","quote_status":"unverified"},{"id":"s9","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41349847/","title":"Cerebroprotection in acute ischemic stroke: Perspectives on combining Cerebrolysin with recanalization therapy","quote":"This article provides perspectives on the use of Cerebrolysin as an adjunct treatment to reperfusion therapy in acute ischemic stroke (AIS).","link_status":"ok","quote_status":"verified"}]},"rationale":"auto-populate round 2","tokens_in":0,"tokens_out":0,"cost":0,"prev_hash":"3124f8727002d44ac332811f19ef6ce5a6044c2ee998b2193cde18c4ee965c57","hash":"79b06fc59030de303f53c2055a92c5265042f568763703af596aca4fa600448d"}],"provenance":[{"ts":"2026-06-29T16:53:56.542Z","model":"grok-4.3","action":"populate-init","prompt":"","input":"","response":"","tokens_in":0,"tokens_out":0,"cost":0,"prev":"genesis","hash":"cf4e7d7fcdfd3e20a74328cf482cc8cbbf52e41ee6e32fa4c9a7b7e4d14b5b49"},{"ts":"2026-06-29T16:54:15.944Z","model":"grok-4.3","action":"sources","prompt":"","input":"cerebrolysin","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"cf4e7d7fcdfd3e20a74328cf482cc8cbbf52e41ee6e32fa4c9a7b7e4d14b5b49","hash":"660b764ee2a8735e3a9bcd4ed7116ff3b031e307281b44d8fd7f658e5708e19f"},{"ts":"2026-06-29T16:54:38.394Z","model":"grok-4.3","action":"sources","prompt":"","input":"cerebrolysin","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"660b764ee2a8735e3a9bcd4ed7116ff3b031e307281b44d8fd7f658e5708e19f","hash":"24a04290baac6e60ad49999bd6e38357bef7ee8b2dea247c4c88662de7db6fda"},{"ts":"2026-07-17T02:38:44.223Z","model":"owner","action":"voxel_divide","prompt":"","input":"cerebrolysin","response":"2 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"24a04290baac6e60ad49999bd6e38357bef7ee8b2dea247c4c88662de7db6fda","hash":"de1c7fe7299216b9312eb8e116eb69c71d7f33e949e28b104cbb527e488908df"}],"energy":{"passes":4,"tokens_in":0,"tokens_out":0,"tokens_total":0,"cost_usd":0,"models":{"grok-4.3":3,"owner":1},"head":"de1c7fe7299216b9312eb8e116eb69c71d7f33e949e28b104cbb527e488908df"},"posted_at":"2026-06-29T16:53:56.542Z","created_at":"2026-06-29T16:53:56.542Z","updated_at":"2026-07-17T02:38:44.223Z","machine":{"shape":"article.machine/v1","slug":"cerebrolysin","kind":"article","read":{"human":"https://miscsubjects.com/a/cerebrolysin","json":"https://miscsubjects.com/api/articles/cerebrolysin","bundle":"https://miscsubjects.com/api/articles/cerebrolysin/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":0,"sources":9,"contributions":3,"revisions":2,"objections_url":"https://miscsubjects.com/api/articles/cerebrolysin/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=cerebrolysin","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"cerebrolysin\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"cerebrolysin\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/cerebrolysin/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"cerebrolysin\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/cerebrolysin | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/cerebrolysin","json":"/api/articles/cerebrolysin","markdown":"/api/articles/cerebrolysin/bundle?format=markdown","skill":"/api/articles/cerebrolysin/skill","topology":"/api/articles/cerebrolysin/topology","versions":"/api/articles/cerebrolysin/revisions","invocations":"/api/articles/cerebrolysin/invocations"},"editorial_review":null,"editorial_audit":{"slug":"cerebrolysin","ok":false,"issues":[{"code":"headline_quality","message":"headline is too short to orient a cold reader; name the subject and event: \"cerebrolysin\"","replacement":"Write a shorter literal headline naming the article subject and its central event or claim."},{"code":"heading_filing_label","message":"section heading “Overview” is a filing label that gives a cold reader no claim","replacement":"Replace “Overview” with the concrete claim, event, or object introduced in that section."},{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"dcd6b7bdb3704e6e308dd7c9e774bd45269f7b4d7d44b04b150e3024d021c061","object":{"object_type":"article-object","identity":{"id":"article:cerebrolysin","slug":"cerebrolysin","title":"cerebrolysin"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/cerebrolysin","role":"explain","audience":"human"},"skill":{"route":"/api/articles/cerebrolysin/skill","role":"direct behavior","audience":"model","content":"---\nname: cerebrolysin\ndescription: Apply the cerebrolysin article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# cerebrolysin\n\nThis Skill is the behavioral expression of [the canonical article](/a/cerebrolysin). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/cerebrolysin.\n- Read claims and relationships at /api/articles/cerebrolysin/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nOverview Evidence is being populated by Grok web search.\n\n## Representations\n\n- Human: /a/cerebrolysin\n- JSON: /api/articles/cerebrolysin\n- Relationships: /api/articles/cerebrolysin/topology\n- History: /api/articles/cerebrolysin/revisions\n"},"json":{"route":"/api/articles/cerebrolysin","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/cerebrolysin/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["cerebrolysin"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/cerebrolysin/invocations?status=success","failure_events":"/api/articles/cerebrolysin/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"cerebrolysin","title":"cerebrolysin","body":"## Overview\nEvidence is being populated by Grok web search.","hero":null,"images":[],"style":{},"tags":[],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/cerebrolysin/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/39832667/","title":"The possible role of cerebrolysin in the management of vascular dementia: Leveraging concepts","quote":"CBL could be effective therapeutic strategy in preventing and treating VD by targeting neuroinflammation, BBB injury, and chronic cerebral hypoperfusion.","summary":"2025 review discussing Cerebrolysin (CBL) as a potential treatment for vascular dementia via anti-inflammatory and neuroprotective mechanisms.","author":"","publisher":"","date":"","claim_ids":[],"found_by":"grok-4.3","extra":{},"accessed_at":"2026-06-29T16:54:15.129Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"1286105d9a205b7bcfc12cc03292be2a61fe2fc4d85bcb1e972d89cdd39a4399"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/39957612/","title":"Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study","quote":"Cerebrolysin combined with speech and language therapy offers promising potential for enhancing recovery in poststroke nonfluent aphasia.","summary":"2025 randomized pilot study (ESCAS) showing benefits of Cerebrolysin plus speech therapy for post-stroke aphasia recovery.","author":"","publisher":"","date":"","claim_ids":[],"found_by":"grok-4.3","extra":{},"accessed_at":"2026-06-29T16:54:15.129Z","link_status":"ok","quote_status":"verified","prev":"1286105d9a205b7bcfc12cc03292be2a61fe2fc4d85bcb1e972d89cdd39a4399","hash":"b035aaffced9e5c80d38e031e91553022418dc7d2fe11d3967fcc875358b1c18"},{"id":"s3","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT06897176","title":"Effects of Cerebrolysin on Language Ability in Non-fluent Aphasia After Stroke","quote":"This study aims to measure changes in language ability after adding cerebrolysin to standard treatment for non-fluent aphasia patients with post-stroke ...","summary":"Ongoing 2025 clinical trial evaluating Cerebrolysin for language recovery in post-stroke non-fluent aphasia.","author":"","publisher":"","date":"","claim_ids":[],"found_by":"grok-4.3","extra":{},"accessed_at":"2026-06-29T16:54:15.129Z","link_status":"ok","quote_status":"unverified","prev":"b035aaffced9e5c80d38e031e91553022418dc7d2fe11d3967fcc875358b1c18","hash":"ddcc96d4165b780c8a4220b08b6b5a8c02a1ce3bc0617f4e216ae07cc8e400d5"},{"id":"s4","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT06677502","title":"Cerebrolysin in Critically Ill Patients With Delirium","quote":"Cerebrolysin, 50 mL daily administered intravenously for seven consecutive days, reduces or alleviates the severity of delirium detected by the CAM-ICU test.","summary":"2025 clinical trial testing Cerebrolysin for reducing delirium severity in critically ill patients.","author":"","publisher":"","date":"","claim_ids":[],"found_by":"grok-4.3","extra":{},"accessed_at":"2026-06-29T16:54:15.129Z","link_status":"ok","quote_status":"unverified","prev":"ddcc96d4165b780c8a4220b08b6b5a8c02a1ce3bc0617f4e216ae07cc8e400d5","hash":"0ac9b7421280e331ebd53e60b0f2759d33fc5c14a43d379c7271b8093b3d5f22"},{"id":"s5","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41018475/","title":"Safety and Efficacy of Cerebrolysin for Neurorecovery After Acute Ischemic Stroke","quote":"These findings suggest that Cerebrolysin significantly enhances early neurological recovery after ischemic stroke, with a comparable safety profile.","summary":"2025 study/meta-analysis supporting Cerebrolysin for improved neurorecovery post-ischemic stroke.","author":"","publisher":"","date":"","claim_ids":[],"found_by":"grok-4.3","extra":{},"accessed_at":"2026-06-29T16:54:15.129Z","link_status":"ok","quote_status":"verified","prev":"0ac9b7421280e331ebd53e60b0f2759d33fc5c14a43d379c7271b8093b3d5f22","hash":"e54f5ee0280583394277c94491345066bbc3ea46808106ab606a2e4f24bdde0b"},{"id":"s6","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/40851188/","title":"C-REGS2-A multinational, high-quality comparative ...","quote":"The results of the C-REGS2 study showed the effectiveness and safety of Cerebrolysin treatment for moderate acute IS in real-world clinical practice.","summary":"2025 real-world study (C-REGS2) confirming efficacy and safety of Cerebrolysin in acute ischemic stroke.","author":"","publisher":"","date":"","claim_ids":[],"found_by":"grok-4.3","extra":{},"accessed_at":"2026-06-29T16:54:15.129Z","link_status":"ok","quote_status":"verified","prev":"e54f5ee0280583394277c94491345066bbc3ea46808106ab606a2e4f24bdde0b","hash":"71417b896315d9b314b4f68b02784ad9618d456cdfc55b17efb0f6977966d2e5"},{"id":"s7","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/40325343/","title":"Efficacy of Cerebrolysin Treatment as an Add-On Therapy to Mechanical Thrombectomy in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion in Anterior Circulation: Results of a 3-Month Follow-up of a Prospective, Open Label, Single-Center Study","quote":"Cerebrolysin improved functional outcomes at 90 days, accelerated neurological recovery, and reduced complications post-MT in patients with small ischemic core,","summary":"2025 study showing benefits of Cerebrolysin as add-on to mechanical thrombectomy in acute ischemic stroke.","author":"","publisher":"","date":"","claim_ids":[],"found_by":"grok-4.3","extra":{},"accessed_at":"2026-06-29T16:54:37.763Z","link_status":"ok","quote_status":"verified","prev":"71417b896315d9b314b4f68b02784ad9618d456cdfc55b17efb0f6977966d2e5","hash":"b7799f17e305d4ab9e3a15b82738f8dc174e29b9f9cdf4c953dc0e5b1a6b916c"},{"id":"s8","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41010922/","title":"Evaluating the Effect of Cerebrolysin as an Adjuvant to Standard Therapy in Patients with Acute Ischemic Stroke: A Prospective Observational Study","quote":"Cerebrolysin, a neuropeptide with neuroprotective and neurotrophic properties, may enhance post-stroke recovery . This study evaluated the impact","summary":"2025 prospective observational study on Cerebrolysin adjuvant in acute ischemic stroke.","author":"","publisher":"","date":"","claim_ids":[],"found_by":"grok-4.3","extra":{},"accessed_at":"2026-06-29T16:54:37.763Z","link_status":"ok","quote_status":"unverified","prev":"b7799f17e305d4ab9e3a15b82738f8dc174e29b9f9cdf4c953dc0e5b1a6b916c","hash":"4c40d8d18f06c59ba3cbf412398101cb9c308b3492ffdeae2d2445e9ba307b3e"},{"id":"s9","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41349847/","title":"Cerebroprotection in acute ischemic stroke: Perspectives on combining Cerebrolysin with recanalization therapy","quote":"This article provides perspectives on the use of Cerebrolysin as an adjunct treatment to reperfusion therapy in acute ischemic stroke (AIS).","summary":"2025/2026 perspectives/review on Cerebrolysin with recanalization in AIS.","author":"","publisher":"","date":"","claim_ids":[],"found_by":"grok-4.3","extra":{},"accessed_at":"2026-06-29T16:54:37.763Z","link_status":"ok","quote_status":"verified","prev":"4c40d8d18f06c59ba3cbf412398101cb9c308b3492ffdeae2d2445e9ba307b3e","hash":"b24406f09d2a34983eca65d5f3b458bd037f35c454c8570a508a9984120267d0"}],"reviews":[],"extra":{},"has_traversal":false,"register":"standard","status":"published","revisions":2,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-29T16:53:56.542Z","model":"grok-4.3","role":"writer","action":"draft","payload":{"title":"cerebrolysin","register":"standard","body":"## Overview\nEvidence is being populated by Grok web search.","claims":[],"sources":[]},"rationale":"","tokens_in":0,"tokens_out":0,"cost":0,"prev_hash":"genesis","hash":"e5cdf02f89b701a81266a29e1414292dfff9d2dcc2c2e23a3d7aea480c4d0a4a"},{"seq":1,"id":"k2","ts":"2026-06-29T16:54:15.944Z","model":"grok-4.3","role":"source_hunt","action":"sources","payload":{"added":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/39832667/","title":"The possible role of cerebrolysin in the management of vascular dementia: Leveraging concepts","quote":"CBL could be effective therapeutic strategy in preventing and treating VD by targeting neuroinflammation, BBB injury, and chronic cerebral hypoperfusion.","link_status":"ok","quote_status":"verified"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/39957612/","title":"Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study","quote":"Cerebrolysin combined with speech and language therapy offers promising potential for enhancing recovery in poststroke nonfluent aphasia.","link_status":"ok","quote_status":"verified"},{"id":"s3","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT06897176","title":"Effects of Cerebrolysin on Language Ability in Non-fluent Aphasia After Stroke","quote":"This study aims to measure changes in language ability after adding cerebrolysin to standard treatment for non-fluent aphasia patients with post-stroke ...","link_status":"ok","quote_status":"unverified"},{"id":"s4","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT06677502","title":"Cerebrolysin in Critically Ill Patients With Delirium","quote":"Cerebrolysin, 50 mL daily administered intravenously for seven consecutive days, reduces or alleviates the severity of delirium detected by the CAM-ICU test.","link_status":"ok","quote_status":"unverified"},{"id":"s5","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41018475/","title":"Safety and Efficacy of Cerebrolysin for Neurorecovery After Acute Ischemic Stroke","quote":"These findings suggest that Cerebrolysin significantly enhances early neurological recovery after ischemic stroke, with a comparable safety profile.","link_status":"ok","quote_status":"verified"},{"id":"s6","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/40851188/","title":"C-REGS2-A multinational, high-quality comparative ...","quote":"The results of the C-REGS2 study showed the effectiveness and safety of Cerebrolysin treatment for moderate acute IS in real-world clinical practice.","link_status":"ok","quote_status":"verified"}]},"rationale":"auto-populate round 1","tokens_in":0,"tokens_out":0,"cost":0,"prev_hash":"e5cdf02f89b701a81266a29e1414292dfff9d2dcc2c2e23a3d7aea480c4d0a4a","hash":"3124f8727002d44ac332811f19ef6ce5a6044c2ee998b2193cde18c4ee965c57"},{"seq":2,"id":"k3","ts":"2026-06-29T16:54:38.394Z","model":"grok-4.3","role":"source_hunt","action":"sources","payload":{"added":[{"id":"s7","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/40325343/","title":"Efficacy of Cerebrolysin Treatment as an Add-On Therapy to Mechanical Thrombectomy in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion in Anterior Circulation: Results of a 3-Month Follow-up of a Prospective, Open Label, Single-Center Study","quote":"Cerebrolysin improved functional outcomes at 90 days, accelerated neurological recovery, and reduced complications post-MT in patients with small ischemic core,","link_status":"ok","quote_status":"verified"},{"id":"s8","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41010922/","title":"Evaluating the Effect of Cerebrolysin as an Adjuvant to Standard Therapy in Patients with Acute Ischemic Stroke: A Prospective Observational Study","quote":"Cerebrolysin, a neuropeptide with neuroprotective and neurotrophic properties, may enhance post-stroke recovery . This study evaluated the impact","link_status":"ok","quote_status":"unverified"},{"id":"s9","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/41349847/","title":"Cerebroprotection in acute ischemic stroke: Perspectives on combining Cerebrolysin with recanalization therapy","quote":"This article provides perspectives on the use of Cerebrolysin as an adjunct treatment to reperfusion therapy in acute ischemic stroke (AIS).","link_status":"ok","quote_status":"verified"}]},"rationale":"auto-populate round 2","tokens_in":0,"tokens_out":0,"cost":0,"prev_hash":"3124f8727002d44ac332811f19ef6ce5a6044c2ee998b2193cde18c4ee965c57","hash":"79b06fc59030de303f53c2055a92c5265042f568763703af596aca4fa600448d"}],"provenance":[{"ts":"2026-06-29T16:53:56.542Z","model":"grok-4.3","action":"populate-init","prompt":"","input":"","response":"","tokens_in":0,"tokens_out":0,"cost":0,"prev":"genesis","hash":"cf4e7d7fcdfd3e20a74328cf482cc8cbbf52e41ee6e32fa4c9a7b7e4d14b5b49"},{"ts":"2026-06-29T16:54:15.944Z","model":"grok-4.3","action":"sources","prompt":"","input":"cerebrolysin","response":"6 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"cf4e7d7fcdfd3e20a74328cf482cc8cbbf52e41ee6e32fa4c9a7b7e4d14b5b49","hash":"660b764ee2a8735e3a9bcd4ed7116ff3b031e307281b44d8fd7f658e5708e19f"},{"ts":"2026-06-29T16:54:38.394Z","model":"grok-4.3","action":"sources","prompt":"","input":"cerebrolysin","response":"3 source(s) added","tokens_in":0,"tokens_out":0,"cost":0,"prev":"660b764ee2a8735e3a9bcd4ed7116ff3b031e307281b44d8fd7f658e5708e19f","hash":"24a04290baac6e60ad49999bd6e38357bef7ee8b2dea247c4c88662de7db6fda"},{"ts":"2026-07-17T02:38:44.223Z","model":"owner","action":"voxel_divide","prompt":"","input":"cerebrolysin","response":"2 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"24a04290baac6e60ad49999bd6e38357bef7ee8b2dea247c4c88662de7db6fda","hash":"de1c7fe7299216b9312eb8e116eb69c71d7f33e949e28b104cbb527e488908df"}],"energy":{"passes":4,"tokens_in":0,"tokens_out":0,"tokens_total":0,"cost_usd":0,"models":{"grok-4.3":3,"owner":1},"head":"de1c7fe7299216b9312eb8e116eb69c71d7f33e949e28b104cbb527e488908df"},"posted_at":"2026-06-29T16:53:56.542Z","created_at":"2026-06-29T16:53:56.542Z","updated_at":"2026-07-17T02:38:44.223Z","machine":{"shape":"article.machine/v1","slug":"cerebrolysin","kind":"article","read":{"human":"https://miscsubjects.com/a/cerebrolysin","json":"https://miscsubjects.com/api/articles/cerebrolysin","bundle":"https://miscsubjects.com/api/articles/cerebrolysin/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":0,"sources":9,"contributions":3,"revisions":2,"objections_url":"https://miscsubjects.com/api/articles/cerebrolysin/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=cerebrolysin","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"cerebrolysin\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"cerebrolysin\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/cerebrolysin/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"cerebrolysin\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/cerebrolysin | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/cerebrolysin","json":"/api/articles/cerebrolysin","markdown":"/api/articles/cerebrolysin/bundle?format=markdown","skill":"/api/articles/cerebrolysin/skill","topology":"/api/articles/cerebrolysin/topology","versions":"/api/articles/cerebrolysin/revisions","invocations":"/api/articles/cerebrolysin/invocations"},"editorial_review":null,"editorial_audit":{"slug":"cerebrolysin","ok":false,"issues":[{"code":"headline_quality","message":"headline is too short to orient a cold reader; name the subject and event: \"cerebrolysin\"","replacement":"Write a shorter literal headline naming the article subject and its central event or claim."},{"code":"heading_filing_label","message":"section heading “Overview” is a filing label that gives a cold reader no claim","replacement":"Replace “Overview” with the concrete claim, event, or object introduced in that section."},{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"dcd6b7bdb3704e6e308dd7c9e774bd45269f7b4d7d44b04b150e3024d021c061"}}}